Literature DB >> 25882807

Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?

Andriana I Papaioannou1, Konstantinos Bartziokas2, Stelios Loukides3, Stamatoula Tsikrika1, Foteini Karakontaki1, Aikaterini Haniotou2, Spyros Papiris3, Daiana Stolz4, Konstantinos Kostikas5.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25882807     DOI： 10.1183/09031936.00237014

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

Review 1.  Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.

Authors:  Chad Wade; J Michael Wells
Journal:  Expert Rev Respir Med       Date:  2020-04-19       Impact factor: 3.772

2.  Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission.

Authors:  Wiebke Bartels; Simon Adamson; Lisa Leung; Don D Sin; Stephan F van Eeden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-23

3.  Coronary lesions in patients with COPD (Global Initiative for Obstructive Lung Disease stages I-III) and suspected or confirmed coronary arterial disease.

Authors:  Igor Larchert Mota; Antônio Carlos Sobral Sousa; Maria Luiza Doria Almeida; Enaldo Vieira de Melo; Eduardo José Pereira Ferreira; José Barreto Neto; Carlos José Oliveira Matos; Caio José Coutinho Leal Telino; Maria Júlia Silveira Souto; Joselina Luzia Menezes Oliveira
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-06-26

4.  Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial Population.

Authors:  Peter Kamstrup; Jannie Marie Bülow Sand; Charlotte Suppli Ulrik; Julie Janner; Christian Philip Rønn; Sarah Rank Rønnow; Diana Julie Leeming; Sidse Graff Jensen; Torgny Wilcke; Alexander G Mathioudakis; Marc Miravitlles; Therese Lapperre; Elisabeth Bendstrup; Ruth Frikke-Schmidt; Daniel D Murray; Theis Itenov; Apostolos Bossios; Susanne Dam Nielsen; Jørgen Vestbo; Tor Biering-Sørensen; Morten Karsdal; Jens-Ulrik Jensen; Pradeesh Sivapalan
Journal:  Biomedicines       Date:  2022-08-19

5.  Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease.

Authors:  Xin Zhang; Lijie Liu; Rui Liang; Shoude Jin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-26

6.  The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.

Authors:  Alberto Papi; Paul W Jones; Prashant S Dalvi; Kirsten McAulay; Tammy McIver; Sanjeeva Dissanayake
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-09

7.  Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients.

Authors:  Björn Ställberg; Christer Janson; Kjell Larsson; Gunnar Johansson; Konstantinos Kostikas; Jean-Bernard Gruenberger; Florian S Gutzwiller; Leif Jorgensen; Milica Uhde; Karin Lisspers
Journal:  NPJ Prim Care Respir Med       Date:  2018-09-10       Impact factor: 2.871
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.